Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Long-Term Deferred Tax (2017 - 2019)

Updated

Amneal Pharmaceuticals (AMRX) reported Long-Term Deferred Tax of $391.88 million for Q2 2019, up 4.9% from $373.71 million a year earlier and up 2.3% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Long-Term Deferred Tax (2017 - 2019) Analysis & Trends

At the end of FY2018, Amneal Pharmaceuticals posted Long-Term Deferred Tax of $373.16 million.

  • By year, Long-Term Deferred Tax came in at $898,000 in FY2017.
  • Per Business Quant data, the three quarters before Q2 2019 came in at $382.94 million (Q1 2019), $373.16 million (Q4 2018) and $365.97 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 391.88 Mn
Mar 31, 2019 382.94 Mn
Dec 31, 2018 373.16 Mn
Sep 30, 2018 365.97 Mn
Jun 30, 2018 373.71 Mn
Dec 31, 2017 898,000.00
API Access

Amneal Pharmaceuticals Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=AMRX&period=max&api_key=YOUR_API_KEY